Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules.
Fuentes-RumÃ, Luna, Hernández-Clares, RocÃo, Carreón-Guarnizo, Ester, Valero-López, Gabriel, Iniesta-Martinez, Francisca, Cabrera-Maqueda, Jose Maria, León-Hernández, Adelaida, Zamarro-Parra, JJournal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2020.102311
Date:
June, 2020
File:
PDF, 715 KB
2020